The great majority of cancers are discovered because of the symptoms that they cause, or because the person concerned (or their doctor) notices a lump or other abnormal appearance. A small but growing proportion of cancers are discovered as a result of doing tests on apparently healthy people who have noticed nothing abnormal. This is called ‘screening’.
Most of the symptoms that can be caused by cancer are far more commonly the result of relatively minor illnesses that have nothing to do with cancer. Sometimes this means that the individual concerned does not take them seriously to start with, and so delays seeking medical advice.
Even when he or she does go, their general practitioner may not always feel that it is appropriate to consider cancer very seriously as a possible diagnosis at this stage. There is really no way around this. Very thorough and immediate investigation of any symptom that might possibly be caused by a cancer would rapidly cause the health service to grind to a halt, not to mention causing a lot of unnecessary anxiety.
Your doctor is more likely to suspect the possibility of a potentially serious cause for a symptom if it persists, or if you have certain other symptoms as well. Some symptoms are sufficiently likely to have a serious explanation that they require further investigation as a routine matter.
Symptoms that could indicate the presence of a cancer include the following.
Persistent and unexplained
- Hoarse voice
- Difficulty with swallowing
- Weight loss
- Altered bowel habit
- Discharge from any orifice (for example, nipple or vagina)
Any abnormal bleeding
- Coughing up blood
- Rectal bleeding
- Vaginal bleeding between periods
- Vaginal bleeding with intercourse
- Postmenopausal vaginal bleeding
- Blood in the urine
- Bleeding from a mole.
Anyone who has any of the above symptoms should seek medical advice promptly. The majority of people with most of these symptoms will not have cancer, but if a cancer is present it is important to diagnose it as early as possible.
Lumps and bumps
The majority of cancers are fairly deep-seated within the body and only a minority can be felt on examination by a doctor, let alone by the patient. However, cancers that are nearer to the surface, such as those involving the breast or testicle, are often discovered by the person becoming aware of a lump. Most skin cancers are also noticed first by the person concerned rather than by his or her doctor.
In fact, few lumps or persistent skin changes turn out to be cancerous. However, if you do notice a lump or if you have a persistent or worsening unexplained ulcer or ‘spot’, particularly any change in appearance of a mole, you should seek medical advice promptly.
Screening for cancer
Screening to discover cancers at an early and more curable stage can help to reduce the number of deaths from a few important types of cancer. However, screening has its problems. If your test result shows up an abnormality that eventually turns out not to be cancer, as often happens, you will have had to go through further investigations and you may have experienced a lot of unnecessary worry and possibly some unnecessary discomfort.
Screening can sometimes reveal the presence of a very slow-growing cancer or a pre-cancerous growth that would not in fact have caused any problems had it not been discovered. As a result some people may receive treatment that is not really necessary. Screening is generally both fairly inefficient and expensive: usually a very large number of people have to be screened to discover one cancer for which earlier diagnosis makes the difference between the success and failure of treatment. It can however sometimes be considerably more effective for individuals who are at a considerably raised risk of developing a certain type of cancer, for example if they have a strong family history.
It is important to remember that screening is not foolproof – however carefully and skilfully done it will fail to spot some cancers. If you develop concerning symptoms you should always seek medical advice as usual and not feel reassured by having recently had a clear screening examination.
Some terms mentioned in the immediately following sections are explained later in this chapter.
Breast cancer screening
Women are currently offered mammography every three years from the age of 50 up to 70, and beyond on request. The age range for routine screening is now in the process of being extended slightly, with invitations being offered to women in their late 40s and up to 73 years. The majority of abnormalities seen on the X-ray pictures are not cancerous, but further investigation including an ultrasound examination of some of them is recommended, sometimes leading to removal of a small piece of tissue (a ‘core biopsy’) for microscopic analysis. A few of these abnormalities are then discovered to be cancerous or pre-cancerous.
The breast cancers discovered in this way are usually small and very treatable and screening reduces, albeit by not a large amount, the average participant’s already fairly low chance of dying from breast cancer. Screening seems to have played a relatively small part in the great improvement in the chance of a cure from breast cancer seen in recent decades: recent estimates suggest that one in approximately 300 women will avoid death from breast cancer as a result of screening over a 20 year period and that for each life approximately three other women will receive unnecessary treatment. If you receive an invitation to attend for screening mammography you should read the accompanying information carefully.
Cervical cancer screening
Sexually active women should have a cervical smear test every three to five years between the ages of 25 and 65. (Women who have never had sexual intercourse rarely get this type of cancer.) When you have a smear test an instrument called a speculum is inserted into the vagina to enable the cervix (neck of the womb) to be seen. The cervix is then scraped gently with a wooden spatula to collect a reasonable number of cells. These are smeared on to a piece of glass and examined under the microscope. The procedure may be a little uncomfortable, but is not normally painful. The test can discover pre-cancerous abnormalities which can easily be dealt with. It can also discover cancers at a very early stage, when the cure rate is high.
Most of the abnormalities discovered in this way are only minor changes, which may require no further investigation, or merely a repeat smear or more frequent smears for a while. However, some abnormalities require further investigation in a procedure called ‘colposcopy’, which involves examining the illuminated cervix with a type of magnifying glass. Tiny samples or ‘punch biopsies’ can be removed from any abnormal areas. This is briefly uncomfortable but it should not be painful and only lasts about 10 minutes.
If potentially pre-cancerous areas are discovered, further treatment to destroy the cells is recommended. This may involve ‘laser evaporation’ (a concentrated beam of light vaporises the abnormal cells), ‘cryotherapy’ (the abnormal cells are destroyed with a freezing probe) under local anaesthetic, or ‘diathermy’ (the abnormal cells are burnt by an electrical probe) under general anaesthetic.
In a small percentage of women the colposcopy may suggest that the abnormality is more serious and a ‘cone biopsy’ (removal of the central lining of the cervical canal) under a general anaesthetic may be necessary. This may well remove all the affected tissue but, occasionally, a more deeply infiltrating growth is discovered which requires more extensive treatment.
Very few women die from cancer of the cervix and, of those who do, almost 90 per cent have never had a routine smear.
Bowel cancer screening
Screening that detects bowel cancers at an earlier stage has been shown to cut the number of deaths from this disease. This commonly involves testing stool specimens for small amounts of blood which are not normally visible to the naked eye. Although the cause of such bleeding is usually something other than cancer, sometimes further investigation by colonoscopy or barium enema will reveal the presence of a cancer before it has grown sufficiently to cause symptoms. Screening using such ‘faecal occult blood’ testing every two years is now offered routinely throughout the UK to people in their sixties and to slightly younger and older age groups depending on the country in which they they live.
Prostate cancer screening
This can be done by testing the blood for a chemical often produced by these cancers – ‘prostate-specific antigen’ or ‘PSA’. If the PSA is raised a ‘digital rectal examination’ or ‘DRE’ is usually recommended (the prostate can easily be felt by a doctor wearing a rubber glove gently inserting a finger into the rectum) and very possibly further investigations including scanning and biopsy. But benignly enlarged prostates can also caused a raised PSA and benign enlargment is very common as men get older: three out of four men with a raised PSA do not have prostate cancer. The value of routine PSA testing is controversial – screening can detect some prostate cancers at an early stage, but it can also result in unnecessary treatment with surgery or radiotherapy and unpleasant side effects including incontinence and impotence. The prostates of most old men dying from other conditions can be found to contain small cancers. Most cancers occurring in elderly people are slow growing and are unlikely to cause problems during the remainder of an individual’s life if left untreated.
The latest evidence indicates that screening can reduce the average participant’s already low chance of dying from prostate cancer, but only very slightly. A very large number of men must be screened to prevent one death from prostate cancer, possibly even more than 1000. In the future ‘genomic testing’ (see below) of early prostate cancers might become widely used to identify those cancers which do potentially pose a threat to life and really need treatment. This could make prostate cancer screening rather more effective and less controversial.
Lung cancer screening
Screening by routine chest X-rays and microscopic examination of sputum for cancer cells has been proven not to be worthwhile. Screening using CT scanning seems to be more effective in picking up early cancers and there is now evidence that this can reduce slightly the chance of dying from lung cancer in heavy smokers. However, the majority of lung cancers appear to carry an unfavourable prognosis from an early stage and at present by far the best hope of significantly reducing deaths from this disease is through a reduction in smoking.
Cancer in families
In theory, it makes sense to screen people who are known (or who are likely) to have inherited a genetic predisposition to cancer. However, fewer than ten per cent of cancers have a clear-cut or identifiable inherited cause. Cancer is a common disease and, when it affects two or more members of the same family, the strong probability is that this is pure chance. Occasionally it may be the result of a shared environmental factor such as smoking.
Hereditary cancer may be suspected when two or more close relatives – parents, brothers or sisters – have either the same cancer or different ones that can sometimes be genetically related, such as those of the breast and ovary. Other hallmarks are the development of the cancer at a young age and a tendency to have bilateral (for example, in both breasts) or multiple tumours.
Some of those with a strong family history may have inherited an identifiable faulty gene. If so it is by no means certain that they will develop a cancer, although inheriting some genes can give an 80 to 90 per cent or even higher risk of developing cancer at some stage. The same type of cancer can sometimes occur in two or more members of a family without any particular genetic abnormality being identifiable. The risk for other members of the family may then be increased, but not usually to a high level.
If you are worried that you may be at an increased risk of cancer because of your family history, you should discuss this with your own doctor. If appropriate you may be referred for a specialised opinion from a clinical geneticist who will want very detailed information about your relatives. You may or may not be offered genetic testing (see below). You may eventually be told that you have little or nothing to worry about. But if you are at increased risk you will be given some idea of how high the risk is.
A predisposition to a variety of rare cancers can be inherited, for example certain tumours of the thyroid and other hormone-producing glands. As far as the more common types of cancer are concerned, the main types that are occasionally inherited are those of the large bowel (colon and rectum), the breast and the ovary. Bowel cancer can occasionally run in families through inheritance of a faulty ‘adenomatosis polyposis coli’ (APC) gene or ‘hereditary non-polyposis colorectal cancer’ (HNPCC) gene. Affected individuals develop multiple benign bowel polyps at an early age and these subsequently become malignant in almost all cases.
Breast cancer is inherited in only five to ten per cent of cases. The known faulty genes that substantially increase the risk of breast cancer include those known as ‘BRCA-1′, ‘BRCA-2′ and ‘TP53′. A woman who has inherited a faulty BRCA-1 or BRCA-2 gene has up to about a 75 per cent chance of developing breast cancer at some stage in her life. A faulty BRCA-1 gene also confers an increased risk of ovarian cancer. However, many women with a family history of breast cancer do not have an inherited mutation of one of these genes. They may be at an increased risk through having another at present unidentifiable genetic abnormality, but the level of risk is usually then much lower, for example below 30 per cent for those with a mother or sister with the disease. BRCA gene abnormalities increase the risk of some other cancers as well, including both breast and prostate cancer in men.
Genetic testing is offered to apparently healthy women if they are thought to be at risk of having a faulty gene predisposing to breast or ovarian cancer. This would be because they are related to someone known to have a faulty gene or if there is a strong family history (and a living family member who has had breast or ovarian cancer is available for testing). Testing is also often offered to women who have been diagnosed with breast cancer and have a suggestive family history.
Genetic testing is carried out on a blood sample. It is however only performed if the individual concerned still wants it done after counselling, which requires very detailed discussion of all the implications, which can be profound. These include consideration of what will be done if a cancer-predisposing gene is discovered, feelings about living with the certain knowledge of high risk, what other family members will be told and the consequences for parenthood. Eligibility for insurance is another potential concern although in the UK there is currently an agreement that people can take out substantial amounts of insurance without having to disclose the results of genetic tests.
Recommendations as to what should be done for those individuals confirmed as being at high risk vary enormously according to the cancer concerned, individual circumstances and preferences. Someone who is facing a high risk of developing hereditary bowel cancer may well be advised to have their colon and rectum removed surgically in their teens or twenties, before the disease has had a chance to develop. When this is done, the small bowel can be joined to the anus, avoiding the need for a permanent ‘stoma’, which is discussed later.
For women with a high risk of breast cancer, choosing the best form of preventive treatment is less straightforward. Some women will opt for prophylactic (that is, preventive) removal of both breasts (bilateral mastectomy). Although this does reduce very substantially the chance of getting breast cancer, it is however not a complete guarantee – a small number of women have developed cancer in the small amount of breast tissue that is left behind after mastectomy. Some women opt instead for a programme of close surveillance involving regular mammography and/or MRI scanning. Hormonal drugs can reduce the risk of breast cancer and two of these, tamoxifen and raloxifene, are now available for women at high risk.
Women at increased risk of ovarian cancer may opt to have both ovaries removed surgically as a preventive measure (bilateral ‘oophorectomy’) but, surprisingly, this again is not guaranteed to completely prevent the disease. Screening to detect ovarian cancer at an early stage using ultrasound scanning and blood testing for the CA-125 ‘tumour marker’ produced by ovarian cancer is an alternative strategy.
If your symptoms suggest the possibility of cancer, or if your doctor finds something unusual during an examination or as the result of a screening test, you will probably need further assessment and tests, depending on the circumstances. Some further investigation may be arranged by your GP, but at some stage you are likely to be referred to a hospital consultant for an opinion on what should be done next. What is appropriate can vary greatly from one individual to another.
Waiting for appointments, further investigations and their results can inevitably be very worrying, but support is usually available from a variety of people and organisations (see ‘Further care and support’ and ‘Further help’).
If you do need further assessment, the first step is likely to be a consultation with a specialist in an outpatient clinic where you will be asked more detailed questions about any symptoms, such as their severity and duration. You can also expect to be asked about your general health and other aspects that may be relevant, such as previous illnesses, any medication you may be taking, present or past occupations, and your home circumstances. It is often helpful if you have all such information ready to hand. This ‘history taking’ will then usually be followed by a physical examination which will tend to concentrate on the part of your body that is giving cause for concern, although you may also have a more generalised examination.
This assessment does not always help in making a diagnosis, but sometimes the doctor will strongly suspect a cancer because he or she finds, for example, a lump that has particular features suggesting malignancy. The physical examination may include taking a look inside some part of your body using instruments: for example, your voice box (‘laryngoscopy’), rectum (‘proctoscopy’) or cervix (by gently inserting a speculum into the vagina).
Although a lump may feel or appear cancerous a definite diagnosis of cancer can usually be made only by a pathologist, a doctor who specialises in assessing cells and tissues by studying them through a microscope. He or she will recognise the characteristic changes in appearance that confirm that cancer is present.
The removal of a piece of tissue for diagnostic purposes is known as a ‘biopsy’. Part of a lump or, if feasible, a whole lump (excision biopsy) may be removed during an operation performed under local or general anaesthetic. Sometimes a thin core of tissue may be removed by a special type of needle device which avoids the need to cut into tissue with a scalpel (‘core biopsy’).
Alternatively, cells from the abnormal tissue may be sucked (‘aspirated’) into a thin needle attached to a syringe. This is called a ‘fine needle aspiration biopsy’ and is usually uncomfortable only very briefly. The cells can then be smeared on to a glass slide. Cells for microscopic examination can also be obtained by scraping the tissue concerned, as in cervical smear testing, or from tissue fluids such as sputum, fluid surrounding the lung (‘pleural effusion’) or urine.
The microscopic examination of very thin processed slices taken from a lump of tissue is known as ‘histology’, whereas the examination of a cellular smear is known as ‘cytology’ Histology can give rather more information because the pathologist is able to assess not only the appearance of individual cells (that is, the bricks) but also the way the tissue is constructed (the architecture).
Cytology is based on the appearance of individual cells. It is capable of establishing the presence of a cancerous process but gives less qualitative information than histology. It also suffers from the potential problem that the cells removed from abnormal tissue by fine needle aspiration may not be representative – the needle may not have sucked up any cancerous cells, even though some were actually present. This risk of a ‘false-negative’ result is not usually a problem with histology. However, a positive cytology result is usually sufficient to justify setting in train further treatment. For many cancers this will involve surgical removal, when tissue will become available for histological examination.
Both histology and cytology have become increasingly complex, as the techniques used to assess the biopsy tissue have becme progressively more sophisticated. In particular a technique called ‘immuno-histochemistry’ often enables the pathologist to differentiate between cancers that would otherwise appear identical. The further information obtained can be very helpful, for example, in assessing more accurately the prognosis and the chance of response to certain treatments.
In recent years it has become increasingly common, using highly sophisticated technology, to analyse the genes present within the cells of a particular cancer, looking for mutations or abnormal activity of certain genes. This is known as ‘genomic testing’ and, being done on the cancer itself, it contrasts with the genetic testing (mentioned in the earlier ‘Cancer in families’ section) done on an apparently normal blood sample to see if a person is carrying a gene which predisposes them to getting cancer. Genomic testing can provide prognostic and other information – for example it can sometimes help in identifying those people who are more likely to need additional chemotherapy following surgery for breast cancer – and it can help in choosing the best drug treatment for some patients with bowel cancer. It seems likely that in future this will become more widely used in an increasingly personalized approach to cancer management.
Biopsies are also sometimes performed in an attempt to establish the extent of the disease, because this can influence substantially the choice of treatment. For example, someone who has a swollen neck gland diagnosed as lymphoma may undergo a bone marrow biopsy to see if there are lymphoma cells in the marrow.
Women with newly diagnosed breast cancer will usually have a biopsy taken from any suspiciously enlarged lymph node in the armpit. However if no suspicious nodes are seen on ultrasound scanning this does not exclude microscopic spread of cancer to one or more of these nodes. It is now routine for most such patients undergoing surgery for the cancer in their breast to have at the same time removal of a crucial lymph node from the armpit (‘sentinel node biopsy’), this node having been meticulously localised after injecting a dye and a radioactive substance into the primary tumour. If this sentinel node ‘draining’ the primary tumour is clear of cancer, it is highly likely that all the other nodes in the armpit will also be clear and the patient can then avoid more extensive armpit surgery with its potentially troublesome side effects.
Words ending in ‘-oscopy’
The term ‘-oscopy’ merely means ‘taking a look’ (skopein is Greek for ‘to see’). Most cancers arise from the inner lining of tubes or containers such as the voice box (larynx), air passages in the lungs (bronchi), swallowing tube or gullet (oesophagus), stomach (for which the medical adjective is ‘gastric’), large bowel (colon and rectum) and bladder (sometimes referred to as ‘cyst’). It is possible to inspect all these structures using a variety of instruments and to take biopsies from any suspicious areas. The names given to these inspections, together with the organs involved, are as follows:
- laryngoscopy: voice box
- bronchoscopy: lungs
- gastroscopy: stomach
- colonoscopy: colon
- sigmoidoscopy: the S-shaped lower end of the colon and rectum
- cystoscopy: bladder,
Other types of inspection include the following:
- nasendoscopy: the air passageway from the nostrils to the larynx
- mediastinoscopy: the tissues behind the breast bone or sternum to assess whether or not a lung cancer has spread to the lymph glands there
- colposcopy: the cervix or neck of the womb
- laparoscopy: the abdominal cavity
Some of these can be performed in the outpatient clinic, some require sedation and some a general anaesthetic. Many now involve the use of fibreoptic technology, which enables the doctor to see down a flexible cable inserted gently into the relevant opening in the body, or through a small cut. Sometimes it is easier for your doctor to see, feel and assess the extent of the growth, and possibly to take a biopsy, while you are under a general anaesthetic. This is known as an examination under anaesthetic or ‘EUA’.
These are unlikely to provide the doctor with much useful information to help make the diagnosis unless the malignancy is of the white blood cells themselves (leukaemia), or if the cancer is one of those types that produce a characteristic chemical or ‘tumour marker’ which can be measured in the blood. These include most cancers of the prostate and testis and myeloma, and some cancers of the bowel, breast, ovary and thyroid gland, but quite often there can be other non-cancerous causes of raised marker levels.
Nevertheless, blood tests can be useful in providing some information on your general state of health. Sometimes they can also suggest that a cancer may have spread to other organs such as the bones or liver. This is when the concentration of certain chemicals known as ‘enzymes’, normally released into the blood by these organs, is above the normal range as a result of damage caused by the cancer.
However, these tests are not foolproof – there are usually several possible causes of such abnormalities other than spread of the cancer.
X-rays and scans
Often the first clear indication of the presence of a cancer is an abnormal appearance on an X-ray or scan, for example, an abnormal white shadow on a chest X-ray caused by a solid lung cancer occupying a space that would normally be filled with healthy air-containing spongy lung tissue. Tumours can also show up on a breast X-ray (mammogram) or on a barium X-ray of the oesophagus, stomach or bowel.
A mammogram is an X-ray picture of the breast taken with the breast compressed between two flat plates. This can sometimes be uncomfortable. Breast cancers usually give characteristic appearances on mammograms, particularly very small white flecks caused by minute deposits of calcium within the cancerous tissue,
When barium is swallowed (barium swallow or meal) or inserted into the bowel via the rectum (barium enema), it shows up densely white on the X-ray, outlining the inner surface of the oesophagus, stomach or bowel. Normally the lining appears smooth but the presence of a cancer can cause it to appear irregular or bulge inwards.
Sometimes other types of ‘dye’ or ‘contrast medium’ showing up white on an X-ray or scan are injected into the bloodstream via a vein. For example, the blood may carry the dye to the kidney which then excretes it into the urine. X-rays taken of the kidney and bladder (intravenous urogram [IVU] or pyelogram [IVP]) can then show up these organs quite clearly and an abnormal appearance may suggest that a cancer is present.
You may need to have one of the various forms of scanning as part of the process of diagnosing cancer or assessing its extent. Computed tomography (CT) and magnetic resonance imaging (MRI) scans require you to lie still in what is usually a large doughnut-shaped structure. CT scanning is now usually very quick. MRI scanning takes somewhat longer, perhaps 15 to 20 minutes, and tends to be rather noisy. These scanners can produce very impressive pictures of cross-sections or ‘slices’ of the part of the body being investigated, and they are often much better at showing growths than simple X-rays. You may have to swallow or have an injection of a ‘contrast medium’. This can help to make any cancer present show up even more clearly.
Ultrasound scanning often involves moving a probe over the skin overlying the relevant part of the body, or sometimes inserting a probe into the rectum, vagina or oesophagus. Images are produced on a screen by detecting very high-frequency, inaudible, ‘sound’ waves reflected off the internal tissues.
Isotope scanning is the creation of a picture by a ‘gamma camera’ which detects gamma rays emitted from the body after you have been injected with or swallowed a radioactive substance known as an isotope. The most common type of isotope scan performed for cancer patients is a bone scan. The injected isotope is carried around the body by the bloodstream, but it tends to home in on or ‘concentrate in’ any areas of bone where there is an attempt at healing any damage, which could have been caused by a tumour that has spread from another part of the body. The high concentration of the harmless isotope at such sites results in their appearance as ‘hot spots’ on the gamma camera picture of the skeleton. Interpretation can sometimes be difficult, however, and hot spots can often be caused by things other than cancer, such as degenerative disease (‘wear and tear’).
Another type of scanning, positron emission tomography (PET), is used in the assessment of some patients with particular cancers. PET scans can sometimes detect tumours that are invisible on other types of scans. It takes advantage of the tendency for special sugars injected into the bloodstream to be ‘taken up’ or absorbed by cancer cells much more rapidly than by normal cells. The sugar molecules have ‘radioactive labels’ attached to them, causing the cancerous tissue to ‘light up’ on the scan pictures.
As well as being used in the initial assessment of people suspected of or diagnosed as having cancer, X-rays and scans are used very commonly to assess response to some treatments, particularly drug treatments. They are sometimes used in certain very specific situations to detect an early curable recurrence not causing any symptoms and they are also used to investigate symptoms which might possibly be caused by a recurrence in someone who has been treated for cancer in the past. However, it is important to realise that none of these ‘radiological’ investigations scans are foolproof: even the most sensitive ones may fail to pick up a very small cancer and they quite often show suspicious abnormalities that turn out to be completely benign.
Once a biopsy has confirmed the presence of a cancer, it will often be allocated to a certain ‘stage’. This describes the size category of the cancer and also indicates whether or not there is evidence that it has invaded adjacent tissues or has spread via the lymphatic vessels to the lymph glands, or through the bloodstream to more distant sites.
Various staging systems are in use but ‘TNM’ staging is the most widespread. ‘T’ refers to the primary tumour, ‘N’ to the lymph nodes and ‘M’ to distant spread (metastasis). A number is allocated to each letter. For example, a woman with a breast cancer three centimetres in diameter which has affected some of the lymph nodes in her armpit, but who does not have any evidence of more distant spread, could be said to have a ‘T2N1M0′ tumour. Here ‘T2′ indicates a primary tumour between two and five centimetres in diameter, ‘N1′ denotes involved but removable lymph nodes confined to the armpit, and ‘M0′ indicates that there has been no detectable distant spread.
Staging can be helpful in estimating prognosis, making recommendations for treatment, and in assessing and comparing the results from treatment.
You should always see your doctor promptly if you have any abnormal bleeding or an unexplained lump
Screening for some cancers can save lives but does have its downsides, and very many people have to be tested for one to benefit
Most cervical cancers can be cured, but almost 90 per cent of those who die from this disease have never had a routine smear
Analysis of a specimen of tissue under the microscope is essential for confirmation of a diagnosis of cancer
X rays and scans are not foolproof